The mRNA expression of FN1 is considered more clinically relevant than the FN1 protein itself, with the FN1 3′-UTR promoting aggressive invasion and metastasis in GC, suggesting that it is a better pharmacological target [45,46]. The gene discussed is FN1; the disease is gastric cancer.